Not applicableStudy completedNCT00744939
What this trial is testing
Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist
Who this might be right for
FibrosisKidney FailureRenal Insufficiency
Bayer 168